These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 578361)

  • 1. Long-term transfer factor treatment in severe atopic dermatitis.
    Thulin H; Ellegaard J; Thestrup-Pedersen K; Zachariae H
    Acta Allergol; 1977 Aug; 32(4):236-7. PubMed ID: 578361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of dialysable transfer factor on IgE concentrations in patients with atopic dermatitis.
    Jarisch R; Eibl M; Sandor I; Boltz A
    Allergy; 1981 Feb; 36(2):99-105. PubMed ID: 6972179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Psychological, immunological, and endocrinological implications of atopic dermatitis].
    Beltrán de Paz C; Flores Sandoval G; Orea Solano M; Gómez Vera J; Serrano Miranda E; Sevilla Flores P; Juárez Rojas Y; Estrada Parra S
    Rev Alerg Mex; 2003; 50(2):54-9. PubMed ID: 12825489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Transfer factor as specific immunomodulator in the treatment of moderate-severe atopic dermatitis].
    Flores Sandoval G; Gómez Vera J; Orea Solano M; López Tiro J; Serrano E; Rodríguez A; Rodríguez A; Estrada Parra S; Jiménez Saab N
    Rev Alerg Mex; 2005; 52(6):215-20. PubMed ID: 16568705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-specific immunotherapy and specific hyposensitization in severe atopic dermatitis.
    Zachariae H; Cramers M; Herlin T; Jensen J; Kragballe K; Ternowitz T; Thestrup-Pedersen K
    Acta Derm Venereol Suppl (Stockh); 1985; 114():48-54. PubMed ID: 3859167
    [No Abstract]   [Full Text] [Related]  

  • 6. [Inflammatory mediators in patients with atopic dermatitis after treatment with transfer factor].
    Orozco TT; Solano MO; Sandoval GF; Vera JG; Parra SE
    Rev Alerg Mex; 2004; 51(4):151-4. PubMed ID: 15491080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PPD and mitogen responsiveness of lymphocytes from patients with atopic dermatitis.
    Thestrup-Pedersen K; Ellegaard J; Thulin H; Zachariare H
    Clin Exp Immunol; 1977 Jan; 27(1):118-26. PubMed ID: 849645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An in vitro study of depressed cell-mediated immunity and of T and B lymphocytes in atopic dermatitis.
    Hovmark A
    Acta Derm Venereol; 1977; 57(3):237-42. PubMed ID: 71829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lymphocyte apoptosis in atopic dermatitis treated with transfer factor].
    García Angeles J; Flores Sandoval G; Orea Solano M; Serrano E; Estrada Parra S
    Rev Alerg Mex; 2003; 50(1):3-7. PubMed ID: 12822541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T and B lymphocytes in contact and atopic dermatitis.
    Secher L; Svejgaard E; Hansen GS
    Br J Dermatol; 1977 Nov; 97(5):537-41. PubMed ID: 303907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of interferon-gamma and interleukin-4 on IgE production in B lymphocytes of patients with atopic dermatitis. A possible criterion for selection of patients for interferon therapy.
    Gruner S; Liebenthal C; Heusser C; Brinkmann V; Zwirner A; Reinicke C; Harnack K; Sönnichsen N; Volk HD
    Acta Derm Venereol; 1991; 71(6):484-7. PubMed ID: 1685830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Atopic dermatitis. Treatment with transfer factor. A controlled clinical trial].
    Valdés Sánchez AF; Fernández Ortega C; Gómez Echeverría AH; Gillama Niebla E; Lastra Alfonso G; López Saura P
    Rev Alerg; 1991; 38(6):158-62. PubMed ID: 1792483
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparative treatment between thalidomide and transfer factor in severe atopic dermatitis].
    Sosa M; Flores G; Estrada S; Orea M; Gómez Vera J
    Rev Alerg Mex; 2001; 48(2):56-64. PubMed ID: 11421176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fc epsilon receptor II/CD23-positive lymphocytes in atopic dermatitis. I. The proportion of Fc epsilon RII+ lymphocytes correlates with the extent of skin lesion.
    Takigawa M; Tamamori T; Horiguchi D; Sakamoto T; Yamada M; Yoshioka A; Toda K; Imamura S; Yodoi J
    Clin Exp Immunol; 1991 May; 84(2):275-82. PubMed ID: 1673878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gamma-interferon therapy for severe cases of atopic dermatitis of the adult type.
    Nishioka K; Matsunaga T; Katayama I
    J Dermatol; 1995 Mar; 22(3):181-5. PubMed ID: 7738273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [IgE and peripheral blood T-lymphocyte levels in patients with atopic dermatitis].
    Samochocki Z; Rudzki E
    Przegl Dermatol; 1990; 77(5):323-6. PubMed ID: 2148628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro immunological studies in atopic and contact dermatitis.
    Bousquet J; Andary M; Clot J; Guilhou DJ; Meynadier J
    Ann Allergy; 1978 Sep; 41(3):170-5. PubMed ID: 686511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune mechanisms in atopic dermatitis and relevance to treatment.
    Leung DY
    Allergy Proc; 1991; 12(5):339-46. PubMed ID: 1959772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An in vitro study of IgE production in severe atopic dermatitis.
    Hovmark A
    Acta Derm Venereol; 1979; 59(3):223-7. PubMed ID: 87079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-mediated immunity in vitro in atopic dermatitis.
    Horsmanheimo M; Horsmanheimo A; Banov CH; Ainsworth SK; Fudenberg HH
    Arch Dermatol; 1979 Feb; 115(2):161-4. PubMed ID: 311620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.